Toxikon showcasing preclinical testing services at DeviceTalks Boston


ToxikonToxikon is a preclinical Contract Research Organization (CRO) located in an FDA registered and ISO 17025 accredited laboratory facility in Bedford, Mass., and a second European lab operation in Leuven, Belgium. The company contracts and partners with biotech, pharmaceutical and medical device industries to deliver product development services from concept to final product. Its professional and scientific staff is experienced in a comprehensive range of compound structures, therapeutic agents, and medical devices, including combinations products.

Featured services:

  • ISO 10993 biocompatibility safety studies (GLP)
  • Preclinical early efficacy and surgical research
  • Chemical characterization/extractables and leachables
  • Cleaning, disinfection and sterilization validations

Visit Toxikon at booth #202 at DeviceTalks Boston.

(Learn from some of the medical device industry’s top executives and experts at DeviceTalks Boston on Oct. 2.)

Want to stay on top of MDO content? Subscribe to our e-newsletter.

Speak Your Mind